US Bancorp’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$367 Buy
296
+57
+24% +$71 ﹤0.01% 4019
2025
Q1
$282 Sell
239
-525
-69% -$619 ﹤0.01% 4060
2024
Q4
$1.4K Sell
764
-733
-49% -$1.34K ﹤0.01% 3907
2024
Q3
$2.55K Sell
1,497
-1,510
-50% -$2.57K ﹤0.01% 3710
2024
Q2
$4.12K Buy
3,007
+84
+3% +$115 ﹤0.01% 3558
2024
Q1
$11K Sell
2,923
-57,777
-95% -$217K ﹤0.01% 3300
2023
Q4
$595K Buy
60,700
+41,816
+221% +$410K ﹤0.01% 1394
2023
Q3
$158K Sell
18,884
-1,381
-7% -$11.5K ﹤0.01% 1938
2023
Q2
$270K Buy
20,265
+16,127
+390% +$214K ﹤0.01% 1710
2023
Q1
$47.9K Sell
4,138
-195
-5% -$2.26K ﹤0.01% 2533
2022
Q4
$35.4K Buy
4,333
+1,036
+31% +$8.47K ﹤0.01% 2700
2022
Q3
$19K Sell
3,297
-231
-7% -$1.33K ﹤0.01% 3034
2022
Q2
$16K Sell
3,528
-22,233
-86% -$101K ﹤0.01% 3171
2022
Q1
$234K Buy
25,761
+2,469
+11% +$22.4K ﹤0.01% 1879
2021
Q4
$477K Buy
23,292
+4,462
+24% +$91.4K ﹤0.01% 1546
2021
Q3
$482K Buy
18,830
+2,778
+17% +$71.1K ﹤0.01% 1535
2021
Q2
$561K Buy
16,052
+1,307
+9% +$45.7K ﹤0.01% 1489
2021
Q1
$491K Buy
14,745
+14,308
+3,274% +$476K ﹤0.01% 1505
2020
Q4
$11K Sell
437
-463
-51% -$11.7K ﹤0.01% 3129
2020
Q3
$9K Hold
900
﹤0.01% 3067
2020
Q2
$3K Hold
900
﹤0.01% 3366
2020
Q1
$3K Buy
900
+500
+125% +$1.67K ﹤0.01% 3312
2019
Q4
$2K Hold
400
﹤0.01% 3434
2019
Q3
$2K Hold
400
﹤0.01% 3431
2019
Q2
$2K Hold
400
﹤0.01% 3464
2019
Q1
$3K Hold
400
﹤0.01% 3357
2018
Q4
$3K Hold
400
﹤0.01% 3328
2018
Q3
$2K Buy
+400
New +$2K ﹤0.01% 3498
2016
Q4
Sell
-2,025
Closed -$18K 3612
2016
Q3
$18K Hold
2,025
﹤0.01% 2855
2016
Q2
$14K Hold
2,025
﹤0.01% 2914
2016
Q1
$17K Buy
+2,025
New +$17K ﹤0.01% 2824